Skip to content
healthcare.dev

Yutrepia

NDC 72964-011, treprostinil, capsule, from Liquidia Technologies, Inc..

Product NDC
72964-011
Status
Listed
Labeler
Liquidia Technologies, Inc.
Dosage form
CAPSULE
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213005
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72964-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TREPROSTINIL SODIUM26.5 ug/1

Pharmacologic classes

Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]

Package NDCNDC-11Package
72964-011-01729640011017 BLISTER PACK in 1 CARTON (72964-011-01) / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8f6d534-115c-440e-bdbb-b443a29bb468

Use it

Look up 72964-011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72964-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72964-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.